Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c

Evidation Health607 enrolled

Overview

The Digital Self-Management Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Self-Management Program on A1c levels for individuals with uncontrolled Type 2 diabetes.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

607

Conditions

Diabetes Mellitus, Type 2

Interventions

Diabetes Self-Management ProgramBEHAVIORAL

The Diabetes Self-Management Program is a platform that includes a smart meter, access to coaching 24/7, and a mobile app and website that help members manage their diabetes. The program offers diabetes education and coaching delivered entirely through the smart meter and mobile app or website.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Humana Medicare Advantage member * Type 2 diabetes diagnosis * HbA1c levels ≥ 8.0% verified by lab test Exclusion Criteria: * Has any of the following conditions: cancer, chronic heart failure, chronic obstructive pulmonary disease, respiratory failure, chronic kidney disease, end stage renal disease, peripheral vascular disease * Not fluent in English * Humana membership is part of a Full or Global risk arrangement * Enrolled in Humana at Home Care Management

Locations (1)

Evidation Health

San Mateo, California, United States

Outcomes

Primary Outcomes

Change from Baseline in A1c at 6 months

Change in A1c from study baseline to study end

Time frame: Baseline and 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.